The role of the pathologist in translational and personalized medicine

Mount Sinai Journal of Medicine

Volumn 74, Issue 1, 2007, Pages 22-26

  Perl, Daniel P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Pathology; Tissue bank; Transgenic; Translational

Indexed keywords

ARTICLE; BIOINFORMATICS; BIOPSY; CANCER GRADING; CLINICAL COMPETENCE; DATA BASE; DISEASE MARKER; ELECTRON MICROSCOPY; EVIDENCE BASED MEDICINE; EXPERIMENTAL MODEL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC DISORDER; HEALTH CARE FACILITY; HUMAN; IMMUNOHISTOCHEMISTRY; INDIVIDUALITY; INDIVIDUALIZATION; MEDICAL PRACTICE; MOLECULAR BIOLOGY; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIOMA; PATHOGENESIS; PATHOLOGIST; PATIENT CARE; PHYSICIAN ATTITUDE; PREVENTIVE MEDICINE; PROTEIN EXPRESSION; TISSUE SECTION; TUMOR CLASSIFICATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; GENETIC SCREENING; GENETICS, MEDICAL; GENOMICS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PATHOLOGY, CLINICAL; PROTEOMICS; TISSUE BANKS;

EID: 34250732794     PISSN: 00272507     EISSN: 19317581     Source Type: Journal    
DOI: 10.1002/msj.20007     Document Type: Article

References (16)

1. Pilarski R, Eng C. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 2004; 41: 323-326.
2. Estey E, Dohner H. Acute myeloid leukaemia. Lancet 2006; 368: 1894-1907.
3. Lopez-Terrada D. Integrating the diagnosis of childhood malignancies. Adv Exp Med Biol 2006; 587: 121-137.
4. Kleihues P, Louis DN, Scheithauer BW, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61: 215- 225; discussion 226-229.
5. Hartmann C, Mueller W, Lass U, Kamel-Reid S, von Deimling A. Molecular genetic analysis of oligodendroglial tumors. J Neuropathol Exp Neurol 2005; 64: 10-14.
6. Hartmann C, Mueller W, von Deimling A. Pathology and molecular genetics of oligodendroglial tumors. J Mol Med 2004; 82: 638-655.
7. Cairncross G, Berkey B, Shaw E, et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 2006; 24: 2707-2714.
8. McDonald JM, See SJ, Tremont IW, et al. The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors. Cancer 2005; 104: 1468-1477.
9. Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007; 356:11-20.
10. Wu Y, Luo Y. Transgenic C. elegans as a model in Alzheimer's research. Curr Alzheimer Res 2005; 2: 37-45.
11. Kretzschmar D. Neurodegenerative mutants in Drosophila: a means to identify genes and mechanisms involved in human diseases? Invert Neurosci 2005; 5: 97-109.
12. Tesson L, Cozzi J, Menoret S, et al. Transgenic modifications of the rat genome. Transgenic Res 2005; 14: 531-546.
13. Games D, Buttini M, Kobayashi D, Schenk D, Seubert P. Mice as models: transgenic approaches and Alzheimer's disease. J Alzheimers Dis 2006; 9: 133-149.
14. Becich MJ. The role of the pathologist as tissue refiner and data miner: the impact of functional genomics on the modem pathology laboratory and the critical roles of pathology informatics and bioinformatics. Mol Diagn 2000; 5: 287-299.
15. Oosterhuis JW, Coebergh JW, van Veen EB. Tumour banks: well-guarded treasures in the interest of patients. Nat Rev Cancer 2003; 3: 73-77.
16. Kaiser J. Court decides tissue samples belong to University, not patients. Science 2006; 312: 346.